Advertisement

Topics

Companies Related to "Fire Needle Therapy on Plaque Psoriasis With Blood Stasis Syndrome∨derfield=score∨derval=DESC" [Most Relevant Company Matches] [Advanced Search Results] RSS

12:24 EDT 17th July 2019 | BioPortfolio

Here are the most relevant search results for "Fire Needle Therapy on Plaque Psoriasis With Blood Stasis Syndrome∨derfield=score∨derval=DESC" found in our extensive corporate database of over 50,000 company records.

Showing "Fire Needle Therapy Plaque Psoriasis With Blood Stasis" Companies 1–25 of 2,100+

Thursday 11th July 2019

Aimmune Therapeutics Inc.

Aimmune Therapeutics, Inc., is a clinical-stage biopharmaceutical company developing treatments for life-threatening food allergies. The company’s Characterized Oral Desensitization ImmunoTherapy (CODIT™) approach is intended to achieve meaningful levels of protection by desensitizing patients with defined, precise amounts of key allergens. Aimmu...


Tuesday 9th July 2019

Dermatology Times®

A multimedia platform for dermatologists, Dermatology Times® provides regulatory and clinical updates, as well as discussion on cost-effective practice management solutions. Dermatology Times® helps dermatology professionals grow their knowledge and advance their practice to improve patient care by providing them with the latest news and trends in dermatologic procedures, therapy, technolog...

Monday 8th July 2019

ATI Physical Therapy

ATI is a privately held, nationally recognized healthcare company, specializing in outpatient rehabilitation and adjacent healthcare services. With a focus on delivering a remarkable experience to every patient, every day, ATI has more than 800 locations from coast to coast. ATI was named “Best Physical Therapy Practice in the Nation” by ADVANCE magazine and was one of the first physica...


Monday 1st July 2019

Sangamo Therapeutics, Inc.

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, in vivo genome editing and gene regulation. For more information about Sangamo, visit www.sangamo.com

RevoluGen

RevoluGen is a small, UK based molecular chemistry research and development company that specialises in HMW-DNA isolation and purification from cell samples specifically for long-read sequencing applications. The combined Fire Monkey / Fire Flower product is RevoluGen’s disruptive first product. Using an innovative combination of chemistry and a spin-column process, RevoluGen has married the...

Friday 28th June 2019

Newron Pharmaceutical S.p.A.

Newron (SIX: NWRN) is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The company is headquartered in Bresso near Milan, Italy. Xadago® (safinamide) has received marketing authorization for the treatment of Parkinson’s disease in the European Union, Switzerland, the US, Australia, Canada, Br...

Wednesday 26th June 2019

Cognito Therapeutics

Cognito Therapeutics is a clinical-stage medical device company developing a non-invasive, in-home neurostimulation therapy platform based on a discovery from founders Professors Li-Huei Tsai and Ed Boyden at MIT, who showed a profound treatment response in mice using gamma entrainment stimulation (GENUS). Their research – published in the journals Nature, Cell and Neuron – showed that ...

Tuesday 25th June 2019

Oska Wellness

Co-founded in 2015 by Greg Houlgate, Oska Wellness is a pioneer of technology-driven wellness solutions that help people live more active lives with less pain. The brand’s cornerstone product, Oska Pulse, is a revolutionary drug-free pain relief device that is clinically proven to reduce inflammation, increase circulation, improve mobility and relieve pain. Oska Pulse utilizes Pulsed Electro...

California Protons Cancer Therapy Center

California Protons’ intensity-modulated pencil beam scanning technology is a highly precise form of cancer radiation treatment that enables doctors to selectively target tumors with high-dose radiation while sparing healthy tissue. California Protons’ pencil beam scanning technology precisely delivers proton radiation treatment within 2 millimete...

The Blood Connection (TBC)

Tuesday 18th June 2019

F-star Therapeutics Ltd.

F-star is a leading clinical-stage biopharmaceutical company delivering tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumour immune evasion, the Company’s goal is to offer patients greater and more durable benefits than current immuno-oncology treatments. Through its proprietary te...

Monday 17th June 2019

IVERIC bio, Inc.

IVERIC bio is a biotechnology company with a focus on the discovery and development of novel gene therapy solutions to treat orphan inherited retinal diseases with unmet medical needs. Vision is Our Mission. For more information on the Company’s gene therapy and other programs, please visit www.ivericbio.com.

Mycovia Pharmaceuticals, Inc

Mycovia Pharmaceuticals has a passion for developing breakthrough therapies in areas of unmet medical need. Our lead product candidate, VT-1161 (oteseconazole), is a novel, oral therapy designed to have greater selectivity, fewer side effects and improved potency than current treatment options. It received FDA Qualified Infectious Disease Product and Fast-...

Wednesday 12th June 2019

IMV IMV Inc.

IMV Inc. is a clinical stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. IMV is pioneering a new class of immunotherapies based on the Company’s proprietary drug delivery platform. This patented technology leverages a ...

Tuesday 11th June 2019

Orpheris

Orpheris is a clinical stage neuroscience company leveraging a novel platform technology from Johns Hopkins that enables the selective delivery of therapeutic agents across the blood barrier into reactive microglial cells. In a number of neurodegenerative diseases such as ALS, Parkinson's, and Alzheimer's, reactive microglia are shown to be responsible for...

AlloVir

AlloVir (formerly ViraCyte), founded in 2013 by researchers at Baylor College of Medicine’s Center for Cell and Gene Therapy, is the leader in the development of novel cell therapies with a focus on restoring natural T-cell immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The company’s...

Wednesday 5th June 2019

OncoMyx Therapeutics

OncoMyx Therapeutics, a startup launched from Arizona State University (ASU), develops oncolytic immunotherapies based on the myxoma virus (MYXV) platform to orchestrate an immune response and treat cancer. Successful immuno-oncology (IO) cancer treatment generally requires combination therapy, and oncolytic viruses (OVs) have emerged as a safe and effecti...

Enzyvant

Enzyvant, a wholly owned subsidiary of Roivant Sciences, is a biotechnology company focused on developing transformative therapies for patients with rare diseases. Enzyvant leverages the Roivant platform to develop therapies that address high unmet medical needs while driving greater efficiency in research, clinical development, and commercialization. The ...

Tuesday 4th June 2019

Prevail Therapeutics Inc.

Prevail Therapeutics is a gene therapy company leveraging breakthroughs in human genetics with the goal of developing and commercializing disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases. Prevail was founded by Dr. Abeliovich in 2017, through a collaborative effort with The Silverstein Foundation for Parkinson’s ...

Vect-Horus

Vect-Horus designs and develops vectors that facilitate targeting and delivery of therapeutic or imaging agents to organs, including the brain and tumours. Vect-Horus combines these different agents to its vectors that specifically target various receptors, allowing these agents to cross natural barriers (first and foremost the blood-brain-barrier) which l...

Friday 31st May 2019

Axis Biotec

Axis Biotec is a private pharmaceutical holding company, specialized in biotechnology, with focus on deploying commercially viable products and services resulting from its investments in R&D. It owns and controls Silvestre Labs, a pharmaceutical company, Cryopraxis, the largest Brazilian stem cell blood bank, Plantpraxis, a R&D company focused in ve...

SFA Therapeutics, Inc.

SFA Therapeutics, Inc. is a bio-pharmaceutical company focused on new human microbiome-based advancements in the treatment of inflammatory diseases, targeting NF-KB mediated pathways. Chronic inflammation has been implicated in a wide range of diseases, including Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Lupus (SLE), Inflammatory Bowel Disease ...

Thursday 30th May 2019

4D Molecular Therapeutics, Inc.

4DMT is focused on the discovery and development of targeted, customized and proprietary next-generation AAV gene therapy products for use in patients with severe genetic diseases with high unmet medical need. 4DMT’s robust discovery platform, termed Therapeutic Vector Evolution, empowers it to create customized gene delivery vehicles that can be desi...

Thrive Earlier Detection Corp.

Today, many cancers are detected at an advanced stage, when the disease has become difficult to treat. This is particularly true for diseases that lack guideline-driven screening tests, such as ovarian, pancreatic and liver cancers, among others. To complement colonoscopy, mammography and other screening tools, Thrive is developing CancerSEEK, a blood-base...

Wednesday 29th May 2019

Imara, Inc.

Imara, Inc. is dedicated to developing novel therapeutics for patients with sickle cell disease and other hemoglobinopathies. Imara is currently developing IMR-687, a highly selective, potent small molecule inhibitor of PDE9, to treat patients with sickle cell disease. IMR-687 has been specifically designed to treat patients with sickle cell disease by bot...


More From BioPortfolio on "Fire Needle Therapy on Plaque Psoriasis With Blood Stasis Syndrome∨derfield=score∨derval=DESC"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks